"The past several decades have been a time of rapid globalization in the development, manufacture, marketing, and distribution of medical products and technologies. Increasingly, research on the safety and effectiveness of new drugs is being conducted in countries with little experience in regulation of medical product development. Demand has been increasing for globally harmonized, science-based standards for the development and evaluation of the safety, quality, and efficacy of medical products. Consistency of such standards could improve the efficiency and clarity of the drug development and evaluation process and, ultimately, promote and enhance product quality and the public health. To explore the need and prospects for greater international regulatory harmonization for drug development, the IOM Forum on Drug Discovery, Development, and Translation hosted a workshop on February 13-14, 2013. Discussions at the workshop helped identify principles, potential approaches, and strategies to advance the development or evolution of more harmonized regulatory standards. This document summarizes the workshop"--

Contents

Introduction

Principles and definitional considerations

Overview of the current global regulatory landscape

Areas of need for harmonized standards and barriers to progress in addressing the gaps

Characteristics of harmonized regulations and regulatory structures

Finding solutions: options and systemic approaches

Tactics and strategies for a way forward.

Description

Mode of access: World wide Web.

Notes

"International Regulatory Harmonization Amid Globalization of Biomedical Research and Medical Product Development: an Institute of Medicine Workshop, February 13-14, 2013, National Academy of Sciences Building Lecture Room."

Includes bibliographical references (pages 77-78).

Copyright & Permissions

Help:

Rights statements and licenses provide information about copyright and reuse associated with individual items in the collection.

a|
"International Regulatory Harmonization Amid Globalization of Biomedical Research and Medical Product Development: an Institute of Medicine Workshop, February 13-14, 2013, National Academy of Sciences Building Lecture Room."

a|
Introduction -- Principles and definitional considerations -- Overview of the current global regulatory landscape -- Areas of need for harmonized standards and barriers to progress in addressing the gaps -- Characteristics of harmonized regulations and regulatory structures -- Finding solutions: options and systemic approaches -- Tactics and strategies for a way forward.

a|
"The past several decades have been a time of rapid globalization in the development, manufacture, marketing, and distribution of medical products and technologies. Increasingly, research on the safety and effectiveness of new drugs is being conducted in countries with little experience in regulation of medical product development. Demand has been increasing for globally harmonized, science-based standards for the development and evaluation of the safety, quality, and efficacy of medical products. Consistency of such standards could improve the efficiency and clarity of the drug development and evaluation process and, ultimately, promote and enhance product quality and the public health. To explore the need and prospects for greater international regulatory harmonization for drug development, the IOM Forum on Drug Discovery, Development, and Translation hosted a workshop on February 13-14, 2013. Discussions at the workshop helped identify principles, potential approaches, and strategies to advance the development or evolution of more harmonized regulatory standards. This document summarizes the workshop"--
c|
Publisher's description.